Skip to main content

Characterization of Gimoti (Metoclopramide Nasal Spray) Dispensing Patterns: A Third Descriptive Analysis

Basic Details
Date Posted
Status
Complete
Medical Product
Gimoti (metoclopramide nasal spray)
Description

In this request, we characterized dispensing patterns of Gimoti™ (metoclopramide nasal spray), stratified by age and sex in the Sentinel Distributed Database (SDD).

The study period includes data from June 19, 2020 to May 31, 2024. We distributed this query to six Sentinel Data Partners on December 12, 2024.

Deliverables (1)
Sentinel Modular Program Report: Characterization of Gimoti (Metoclopramide Nasal Spray) Dispensing Patterns: A Third Descriptive Analysis
Additional Details
FDA Center
CDER
Time Period
June 19, 2020 - May 31, 2024
Analysis Type
Descriptive
Population / Cohort
Individuals 18 years of age and older
Data Sources
Sentinel Distributed Database (SDD)
Related Links
Sentinel Drug Study: Gimoti (Metoclopramide Nasal Spray) & Tardive Dyskinesia and Adverse Central Nervous System Reactions
Characterization of Gimoti (Metoclopramide Nasal Spray) Dispensing Patterns: A Descriptive Analysis
Characterization of Gimoti (Metoclopramide Nasal Spray) Dispensing Patterns: A Second Descriptive Analysis